Infection by the Sylvio X10/4 clone of Trypanosoma cruzi: relevance of a low-virulence model of Chagas' disease

Microbes and Infection

Volumn 11, Issue 13, 2009, Pages 1037-1045

  Marinho, Cláudio R F ^a,b   Nuñez Apaza, Luis N ^a   Bortoluci, Karina R ^a,b   Bombeiro, André L ^a   Bucci, Daniella Z ^a   Grisotto, Marcos G ^a,c   Sardinha, Luiz R ^a   Jorquera, Christian E ^a   Lira, Sergio ^c   D'Império Lima, Maria Regina ^a   Álvarez, José M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Chagas' disease; Heart pathology; Immune response; Parasitaemia; Parasite evasion; Sylvio X10 4 parasites; Trypanosoma cruzi

Indexed keywords

ANIMAL TISSUE; CHAGAS DISEASE; CHRONIC DISEASE; CLONE; DISEASE COURSE; EXPERIMENTAL MODEL; HOST PARASITE INTERACTION; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPETENCE; MOUSE; NONHUMAN; PARASITE VIRULENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; TRYPANOSOMA CRUZI; XENODIAGNOSIS;

ANIMALS; CHAGAS DISEASE; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HOST-PARASITE INTERACTIONS; MICE; PARASITEMIA; TRYPANOSOMA CRUZI;

MURINAE; MUS; TRYPANOSOMA CRUZI;

EID: 70349964710     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2009.07.011     Document Type: Short Survey

References (53)

1. Schofield C.J., Jannin J., and Salvatella R. The future of Chagas disease control. Trends Parasitol. 22 (2006) 583-588 Epub 2006 Oct, 2016
2. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect. Dis. 1 (2001) 92-100
3. Teixeira M.M., Gazzinelli R.T., and Silva J.S. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol. 18 (2002) 262-265
4. Tarleton R.L. Immune system recognition of Trypanosoma cruzi. Curr. Opin. Immunol. 19 (2007) 430-434 Epub 2007 Jul, 2024
5. Kierszenbaum F. Where do we stand on the autoimmunity hypothesis of Chagas disease?. Trends Parasitol 21 (2005) 513-516 Epub 2005 Aug, 2025
6. Mukherjee S., Huang H., Weiss L.M., Costa S., Scharfstein J., and Tanowitz H.B. Role of vasoactive mediators in the pathogenesis of Chagas' disease. Front Biosci. 8 (2003) e410-419
7. Vago A.R., Andrade L.O., Leite A.A., d'Avila Reis D., Macedo A.M., Adad S.J., Tostes Jr. S., Moreira M.C., Filho G.B., and Pena S.D. Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs. Am. J. Pathol. 156 (2000) 1805-1809
8. Andersson J., Orn A., and Sunnemark D. Chronic murine Chagas' disease: the impact of host and parasite genotypes. Immunol. Lett. 86 (2003) 207-212
9. Marinho C.R., Bucci D.Z., Dagli M.L., Bastos K.R., Grisotto M.G., Sardinha L.R., Baptista C.R., Goncalves C.P., Lima M.R., and Alvarez J.M. Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi clone: a model for genetic studies of Chagas' disease. Infect. Immun. 72 (2004) 2350-2357
10. Silveira F., VIana Dias M., Pereira Pardal P., OLiveira Lobao A., and Britto Melo G. Nono caso autóctone de doença de Chagas registrado no estado do Pará, Brasil (Nota prévia). Hileia Med. Belém 1 (1979) 61-62
11. Postan M., Dvorak J.A., and McDaniel J.P. Studies of Trypanosoma cruzi clones in inbred mice. I. A comparison of the course of infection of C3H/HEN- mice with two clones isolated from a common source. Am. J. Trop. Med. Hyg. 32 (1983) 497-506
12. Postan M., Cheever A.W., Dvorak J.A., and McDaniel J.P. A histopathological analysis of the course of myocarditis in C3H/He mice infected with Trypanosoma cruzi clone Sylvio-X10/4. Trans. R. Soc. Trop. Med. Hyg. 80 (1986) 50-55
13. Marinho C.R., Nunez-Apaza L.N., Martins-Santos R., Bastos K.R., Bombeiro A.L., Bucci D.Z., Sardinha L.R., Lima M.R., and Alvarez J.M. IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites. Scand. J. Immunol. 66 (2007) 297-308
14. Claser C., Espindola N.M., Sasso G., Vaz A.J., Boscardin S.B., and Rodrigues M.M. Immunologically relevant strain polymorphism in the Amastigote Surface Protein 2 of Trypanosoma cruzi. Microbes Infect. 9 (2007) 1011-1019 Epub 2007 Apr, 1019
15. Yoshida N. Surface antigens of metacyclic trypomastigotes of Trypanosoma cruzi. Infect. Immun. 40 (1983) 836-839
16. Koga R., Hamano S., Kuwata H., Atarashi K., Ogawa M., Hisaeda H., Yamamoto M., Akira S., Himeno K., Matsumoto M., and Takeda K. TLR-dependent induction of IFN-beta mediates host defense against Trypanosoma cruzi. J. Immunol. 177 (2006) 7059-7066
17. +) T lymphocytes. Infect. Immun. 57 (1989) 2246-2248
18. Tarleton R.L., Koller B.H., Latour A., and Postan M. Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356 (1992) 338-340
19. Rodriguez A.M., Santoro F., Afchain D., Bazin H., and Capron A. Trypanosoma cruzi infection in B-cell-deficient rats. Infect. Immun. 31 (1981) 524-529
20. Umekita L.F., and Mota I. How are antibodies involved in the protective mechanism of susceptible mice infected with T. cruzi?. Braz. J. Med. Biol. Res. 33 (2000) 253-258
21. Cardillo F., Voltarelli J.C., Reed S.G., and Silva J.S. Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect. Immun. 64 (1996) 128-134
22. Sardinha L.R., Elias R.M., Mosca T., Bastos K.R., Marinho C.R., D'Imperio Lima M.R., and Alvarez J.M. Contribution of NK, NK T, gammadelta T, and alphabeta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi. Infect. Immun. 74 (2006) 2031-2042
23. Reed S.G. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. J. Immunol. 140 (1988) 4342-4347
24. Gazzinelli R.T., Oswald I.P., Hieny S., James S.L., and Sher A. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an l-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur. J. Immunol. 22 (1992) 2501-2506
25. Santiago H.C., Feng C.G., Bafica A., Roffe E., Arantes R.M., Cheever A., Taylor G., Vieira L.Q., Aliberti J., Gazzinelli R.T., and Sher A. Mice deficient in LRG-47 display enhanced susceptibility to Trypanosoma cruzi infection associated with defective hemopoiesis and intracellular control of parasite growth. J. Immunol. 175 (2005) 8165-8172
26. Cummings K.L., and Tarleton R.L. Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice. Infect. Immun. 72 (2004) 4081-4089
27. Saeftel M., Fleischer B., and Hoerauf A. Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection. Infect. Immun. 69 (2001) 2252-2259
28. Holscher C., Kohler G., Muller U., Mossmann H., Schaub G.A., and Brombacher F. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect. Immun. 66 (1998) 1208-1215
29. + T cells in response to Trypanosoma cruzi infection. Microbes Infect. 6 (2004) 1133-1144
30. Marinho C.R., D'Imperio Lima M.R., Grisotto M.G., and Alvarez J.M. Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease. Infect. Immun. 67 (1999) 308-318
31. + T cell function to immune control of Trypanosoma cruzi. Parasite Immunol. 20 (1998) 207-216
32. Tarleton R.L., Grusby M.J., Postan M., and Glimcher L.H. Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int. Immunol. 8 (1996) 13-22
33. + T lymphocytes in the inflammatory lesions of mice with acute Trypanosoma cruzi infection. Am. J. Trop. Med. Hyg. 48 (1993) 161-169
34. Zhang L., and Tarleton R.L. Persistent production of inflammatory and anti-inflammatory cytokines and associated MHC and adhesion molecule expression at the site of infection and disease in experimental Trypanosoma cruzi infections. Exp. Parasitol. 84 (1996) 203-213
35. Ribeiro Dos Santos R., and Hudson L. Trypanosoma cruzi: immunological consequences of parasite modification of host cells. Clin. Exp. Immunol. 40 (1980) 36-41
36. Cunha-Neto E., Duranti M., Gruber A., Zingales B., De Messias I., Stolf N., Bellotti G., Patarroyo M.E., Pilleggi F., and Kalil J. Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 3541-3545
37. Zhang L., and Tarleton R.L. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. J. Infect. Dis. 180 (1999) 480-486
38. Anez N., Carrasco H., Parada H., Crisante G., Rojas A., Fuenmayor C., Gonzalez N., Percoco G., Borges R., Guevara P., and Ramirez J.L. Myocardial parasite persistence in chronic chagasic patients. Am. J. Trop. Med. Hyg. 60 (1999) 726-732
39. Palomino S.A., Aiello V.D., and Higuchi M.L. Systematic mapping of hearts from chronic chagasic patients: the association between the occurrence of histopathological lesions and Trypanosoma cruzi antigens. Ann. Trop. Med. Parasitol. 94 (2000) 571-579
40. Sterin-Borda L., and Borda E. Role of neurotransmitter autoantibodies in the pathogenesis of chagasic peripheral dysautonomia. Ann. N. Y. Acad. Sci. 917 (2000) 273-280
41. Tarleton R.L., Zhang L., and Downs M.O. "Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 3932-3937
42. Chandrasekar B., Melby P.C., Troyer D.A., Colston J.T., and Freeman G.L. Temporal expression of pro-inflammatory cytokines and inducible nitric oxide synthase in experimental acute Chagasic cardiomyopathy. Am. J. Pathol. 152 (1998) 925-934
43. Machado F.S., Martins G.A., Aliberti J.C., Mestriner F.L., Cunha F.Q., and Silva J.S. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 102 (2000) 3003-3008
44. Vianna G. Contribuição para o estudo da Anatomia Patológica da Molestia de Carlos Chagas. Memor. Inst. Oswaldo Cruz 3 (1911) 276
45. Petersen C.A., Krumholz K.A., and Burleigh B.A. Toll-like receptor 2 regulates interleukin-1beta-dependent cardiomyocyte hypertrophy triggered by Trypanosoma cruzi. Infect. Immun. 73 (2005) 6974-6980
46. de Souza E.M., Araujo-Jorge T.C., Bailly C., Lansiaux A., Batista M.M., Oliveira G.M., and Soeiro M.N. Host and parasite apoptosis following Trypanosoma cruzi infection in in vitro and in vivo models. Cell Tissue Res. 314 (2003) 223-235 Epub 2003 Aug, 2020
47. Aoki Mdel P., Cano R.C., Pellegrini A.V., Tanos T., Guinazu N.L., Coso O.A., and Gea S. Different signaling pathways are involved in cardiomyocyte survival induced by a Trypanosoma cruzi glycoprotein. Microbes Infect. 8 (2006) 1723-1731 Epub 2006 Apr, 1721
48. Hall B.S., Tam W., Sen R., and Pereira M.E. Cell-specific activation of nuclear factor-kappaB by the parasite Trypanosoma cruzi promotes resistance to intracellular infection. Mol. Biol. Cell 11 (2000) 153-160
49. Kipnis T.L., and da Silva W.D. Evasion of Trypanosoma cruzi from complement lysis. Braz. J. Med. Biol. Res. 22 (1989) 1-16
50. Nogueira N., and Cohn Z. Trypanosoma cruzi: mechanism of entry and intracellular fate in mammalian cells. J. Exp. Med. 143 (1976) 1402-1420
51. + T cell dysfunction during experimental Trypanosoma cruzi infection. Eur. J. Immunol. 37 (2007) 2764-2771
52. Raberg L., Sim D., and Read A.F. Disentangling genetic variation for resistance and tolerance to infectious diseases in animals. Science 318 (2007) 812-814
53. Ramasawmy R., Fae K.C., Cunha-Neto E., Muller N.G., Cavalcanti V.L., Ferreira R.C., Drigo S.A., Ianni B., Mady C., Goldberg A.C., and Kalil J. Polymorphisms in the gene for lymphotoxin-alpha predispose to chronic Chagas cardiomyopathy. J. Infect. Dis. 196 (2007) 1836-1843